Browse the corpus

Carbon disulfide (CS2) is a colorless liquid at room temperature, which emits a sweet, aromatic odor in its pure form. However, the presence of additives such as hydrogen sulfide can alter its characteristics, resulting in a yellowish tint and an unpleasant aroma similar to that of decaying radish or overcooked cauliflower. CS2 is widely used in various industrial processes, including the production of substances such as rayon, cellophane, dyes, and rubbers. CS2 is also used as a pesticide, fruit preservative, solvent, and cleaner.[1] In nature, CS2 can also be found in marshes, lakes, volcanoes, and areas affected by wildfires.[2] As it is readily reactive when exposed to air, CS2 is transported in liquid form and is classified as flammable and explosive. Exposure to CS2 primarily occurs through inhalation, as the substance is rapidly absorbed by the respiratory system. Even at low concentrations (measured in parts per million [ppm]), it can cause irritation and a range of symptoms. High levels of exposure may lead to more severe outcomes, including respiratory distress, central nervous system (CNS) dysfunction, and, in extreme cases, coma. The degree of toxicity depends on several factors, including the concentration of the substance and the duration of exposure.[2] The chronicity of CS2 exposure can affect how individuals present clinically. Acute exposure can cause various symptoms—from vague and nonspecific complaints to severe toxicity requiring critical care. Symptoms may include headache, cough, lightheadedness, and shortness of breath. In more severe cases, acute exposure can lead to respiratory distress, acute confusion, or even obtundation. Chronic exposure is associated with long-term health effects such as chronic lung disease, increased risk of cardiovascular disease, and renal impairment. Healthcare workers should be diligent in obtaining a detailed occupational history, as factory workers may be at a greater risk of exposure to hazardous substances, such as CS2.

The chronicity of CS2 exposure can affect how individuals present clinically. Acute exposure can cause various symptoms—from vague and nonspecific complaints to severe toxicity requiring critical care. Symptoms may include headache, cough, lightheadedness, and shortness of breath. In more severe cases, acute exposure can lead to respiratory distress, acute confusion, or even obtundation. Chronic exposure is associated with long-term health effects such as chronic lung disease, increased risk of cardiovascular disease, and renal impairment. Healthcare workers should be diligent in obtaining a detailed occupational history, as factory workers may be at a greater risk of exposure to hazardous substances, such as CS2. Given the widespread industrial use of CS2, the potential for chronic exposure and associated long-term health effects must be carefully considered. Exposure to CS2—whether from occupational or environmental sources—can cause respiratory tract irritation, eye irritation, and headaches. Regulatory agencies have established exposure limits to reduce health risks, typically setting permissible levels between 10 and 20 ppm.[1][2] Despite regulatory efforts, hazardous incidents involving CS2 continue to pose significant health risks due to the potential for large-scale exposure to this substance. Several international events have been reported in which industrial accidents led to severe health complications. In Korea, between the late 1980s and early 1990s, numerous workers at a rayon plant were exposed to high levels of CS2. This subsequently led to extensive epidemiological studies of individuals exposed to higher amounts of CS2 over time.[3] In 1994, a major leak at a viscose rayon plant in India exposed both workers and nearby residents to dangerous concentrations of CS2.[1] Similarly, in 1996, a railroad tank car accident in Tennessee released a large amount of CS2 into the surrounding community, resulting in the evacuation of approximately 500 people.[1]

CS2 primarily affects individuals through inhalation. Factory workers and others in industrial settings face a higher risk of exposure. Acceptable exposure limits typically range from 10 to 20 ppm.[2][3] Various animal studies have demonstrated that symptoms can occur at levels ranging from 1 to 10 ppm following acute exposure. Respiratory symptoms may develop at concentrations as low as 1 ppm, while lethal levels have been reported around 500 ppm.[1][2] The effects of chronic exposure to CS2 have been extensively studied. Maintaining exposure levels below 10 ppm is recommended, as prolonged exposure above this threshold can lead to significant health effects. In particular, multiple studies have demonstrated an increased risk of cardiovascular disease with chronic exposure at levels around 20 ppm.[1][2] Symptoms have also been reported at exposure levels within the 10- to 20-ppm range.[2] In cases of acute exposure, symptoms can develop rapidly, starting with nonspecific or constitutional complaints such as headache, shortness of breath, and irritation of the eyes and mucous membranes. These effects have been observed at concentrations ranging from 17 to 51 ppm.[4] Although lower-dose exposures may produce mild and transient symptoms that resolve upon removal from the source, prolonged exposure can lead to symptoms that are slower to resolve and may become persistent and long-lasting over time. At concentrations between 20 and 400 ppm, individuals may develop significant CNS disturbances.[1][4][5] Respiratory symptoms may worsen, and cutaneous manifestations can also occur. Exposure levels exceeding 2000 ppm can lead to severe CNS depression and respiratory compromise. Such high-volume exposures typically result from industrial accidents or ingestion of liquid CS2. Although acute exposures are uncommon and often involve small quantities, chronic exposure remains a concern due to its potential to cause adverse health effects.[3]

At concentrations between 20 and 400 ppm, individuals may develop significant CNS disturbances.[1][4][5] Respiratory symptoms may worsen, and cutaneous manifestations can also occur. Exposure levels exceeding 2000 ppm can lead to severe CNS depression and respiratory compromise. Such high-volume exposures typically result from industrial accidents or ingestion of liquid CS2. Although acute exposures are uncommon and often involve small quantities, chronic exposure remains a concern due to its potential to cause adverse health effects.[3] Chronic exposure to CS2 is most commonly seen in factory workers who are exposed to low-dose CS2 over many years. Although acute symptoms may not develop, cumulative exposure can lead to a range of chronic health issues. Chronic lung disease is one of the most frequent outcomes, with CS2 recognized as a significant contributor to progressive lung damage. Additionally, workers exposed to CS2 may develop coronary artery disease, renal disease, and neurological symptoms.[2] These neurological symptoms can include neuropathy, vertigo, pseudobulbar signs, and paralysis. Given the severe long-term risks, minimizing exposure through proper protective measures is essential. CS2 toxicity is primarily associated with occupational exposure, although environmental and accidental exposures have also been reported. The highest-risk populations include workers in industries where CS2 is commonly used, such as rayon manufacturing (historically the most significant source of exposure), pesticide production, rubber manufacturing, chemical production, and solvent use.[1] Several studies have identified that workers in these industries are often exposed to CS2 levels well above established safety limits, placing them at a high risk of toxicity. Although occupational exposure remains the primary source of CS2 toxicity, occasional environmental exposures have also been reported, particularly near industrial facilities or after accidental spills. Additionally, CS2 can occur naturally in the environment, primarily in areas surrounding marshes, lakes, and volcanic regions.[2]

CS2 toxicity is primarily associated with occupational exposure, although environmental and accidental exposures have also been reported. The highest-risk populations include workers in industries where CS2 is commonly used, such as rayon manufacturing (historically the most significant source of exposure), pesticide production, rubber manufacturing, chemical production, and solvent use.[1] Several studies have identified that workers in these industries are often exposed to CS2 levels well above established safety limits, placing them at a high risk of toxicity. Although occupational exposure remains the primary source of CS2 toxicity, occasional environmental exposures have also been reported, particularly near industrial facilities or after accidental spills. Additionally, CS2 can occur naturally in the environment, primarily in areas surrounding marshes, lakes, and volcanic regions.[2] CS2 is volatile and has low environmental longevity. However, it can still pose risks in poorly ventilated areas or where safety protocols are not adequately followed. Regulatory standards and improved safety protocols have helped reduce occupational exposure and the incidence of acute toxicity, though long-term health risks persist. Countries with active rayon and chemical industries, such as China, India, and regions of Southeast Asia, continue to report occupational health concerns related to CS2. Moreover, underdeveloped countries with manufacturing facilities face even greater exposure risks due to inadequate regulations and safety standards.

Numerous studies have reported CNS toxicity associated with CS2 exposure.[6][7][8] In addition, a study found that female workers exposed to CS2 had a higher incidence of adverse pregnancy outcomes, including preterm birth, congenital malformations, emesis gravidarum, and preeclampsia.[9] Another study involving rayon factory workers demonstrated significantly slower sensory and motor nerve conduction velocities, alongside increased self-reported rates of depression.[10] Although the carcinogenic potential of CS2 has not been extensively studied, prior research linked occupational exposure in rubber industry workers to higher mortality from lymphatic leukemia.[11] These risks may be compounded by smoking, which has a synergistic effect.[12] CS2 exposure is also strongly associated with an increased risk of cardiovascular disease. An interventional study that followed a cohort of rayon mill workers in Finland over 5 years reported a 4.7-fold increase in heart disease–related mortality among those exposed to CS2. An intervention aimed to reduce CS2 exposure successfully normalized this risk.[13][14]

The exact mechanism of CS2 toxicity is not fully understood, but it likely involves multiple direct effects on various organ systems.[15][16] Following absorption, CS2 is metabolized into acid-labile dithiocarbamate compounds. These metabolites are believed to contribute to its toxic effects, including the inhibition of dopamine beta-hydroxylase (DBH)—an enzyme responsible for converting dopamine to norepinephrine in the brain.[17][18] This partly accounts for some of the neurological symptoms reported in CS2 exposures. Additionally, CS2 exposure is linked to pyridoxine (vitamin B6) deficiency, resulting in reduced production of gamma-aminobutyric acid (GABA), which may lead to benzodiazepine-resistant seizures.[1] CS2 also alters the metabolism of vitamin B6, further exacerbating deficiency. These effects are compounded by oxidative damage and inflammation, which can impact multiple organ systems exposed to CS2.[1] CS2 also affects hepatic function by altering the liver’s ability to metabolize lipids, which can lead to elevated serum cholesterol levels. This disruption may contribute to the increased rates of atherosclerosis observed in individuals with chronic exposures to CS2. Additionally, several studies suggest that CS2 may inhibit aldehyde dehydrogenase (ALDH), resulting in higher acetaldehyde concentrations and a potential increased risk of disulfiram-like reactions.[1][16][19] CS2 may also inhibit nitric oxide synthase, leading to reduced nitric oxide levels. This decrease can significantly impact the reproductive system, resulting in lowered levels of gonadotropin-releasing hormone, luteinizing hormone, sperm motility, sperm count, and testosterone.[20] Conversely, CS2 exposure may increase follicle-stimulating hormone concentrations, collectively contributing to decreased libido, infertility, and overall reproductive dysfunction.[1][21][22] Common metabolites of CS2 include thiourea and 2-thiothiazolidine-4-carboxylic acid (TTCA). TTCA, in particular, has been associated with impaired lung function, including reduced pulmonary capacity. Studies indicate that higher exposure levels correspond with a reduced FEV1/FVC ratio compared to lower exposure levels.[23] TTCA can also serve as a biomarker to monitor clearance after exposure, as its levels are detectable in urine.[1][22]

Acute CS2 toxicity commonly presents with respiratory symptoms such as shortness of breath, bronchospasm, wheezing, and hypoxia. Constitutional symptoms, including nausea, vomiting, headache, lightheadedness, and dizziness, are also frequently reported following acute exposure to the substance. As exposure levels increase, both the number and severity of symptoms intensify, with high-dose exposures potentially resulting in CNS depression, paralysis, and coma.[1][4][24] Chronic exposure to CS2 can lead to a range of long-term health conditions, most notably chronic lung disease and cardiovascular disease. Additional complications may include microangiopathy, peripheral neuropathy, kidney disease, and reproductive dysfunction.[25] CS2 affects multiple organ systems with varying degrees of severity, as mentioned below. Central nervous system: Headaches, nausea, dizziness, hallucinations, mania, psychosis, seizures, coma, neuropathy, vertigo, vomiting, central paralysis, and narcosis.[5][17][18][24] Respiratory: Wheezing, coughing, upper airway irritation, and dyspnea. Ocular: Corneal burns, conjunctivitis, retinopathy, blurred vision, and eye irritation. Cardiac: Coronary artery disease, chest pain, and palpitations.[26][27] Dermal: Pain, redness, blisters, and chemical burns (second- and third-degree). Gastrointestinal: Nausea, vomiting, and abdominal pain. Renal: Acute kidney injury, increased 24-hour glucose clearance, and elevated urinary protein concentration.[6][25] Genitourinary: Reduced sperm count, altered sperm morphology and hormone levels, decreased libido and potency, and spontaneous abortions.[20][21]

CS2 has limited diagnostic testing options. Research has been conducted on various endpoints to determine the exposure and clearance of CS2; however, its clinical utility is limited. For instance, TTCA can correlate with exposure amount in cases of known CS2 exposure. Low levels can also be detected in individuals without known exposure to CS2, which is believed to be related to dietary sources.[2][23] Furthermore, treatment is primarily based on symptom management and reduction of adverse outcomes rather than acutely trying to address CS2 toxicity. Initial evaluation and workup of individuals exposed to CS2 should prioritize stabilization, followed by assessment for signs of organ injury. In critically ill patients, addressing the critical needs is first and foremost. Decontamination must be performed promptly as the initial step to prevent further exposure and protect both the patient and healthcare staff, as well as those caring for the individual. Individuals who were exposed to high levels of CS2 may require intubation for respiratory compromise and vasopressor support for circulatory instability. Following stabilization, laboratory and diagnostic evaluations should focus on assessing potential damage to the cardiovascular system, kidneys, and lungs. Considering the possibility of additional toxic exposures or alternative diagnoses is also important. Diagnostic testing may include an electrocardiogram (ECG), chest x-ray, and computed tomography (CT) scan. Laboratory assessments such as a complete blood count, comprehensive metabolic panel, lipase, liver function tests, arterial or venous blood gas, troponin, coagulation profile, salicylate and acetaminophen levels, ethanol level, urinalysis, urine drug screen, and pregnancy test (if applicable) can help identify evidence of end-organ damage and guide further management.

Antidotes for the treatment of CS2 toxicity do not exist; therefore, treatment is primarily supportive and focused on treating symptoms related to exposure. Early recognition and intervention are crucial, with a particular focus on respiratory and neurological complications.[1] The risk of secondary exposure to healthcare providers is low, especially once the patient has been removed from the source. This is primarily due to the high volatility and rapid dissipation of CS2 gas at standard temperature and pressure. Although the risk of secondary contamination in CS2 toxicity is generally low, significant exposures—particularly to the liquid form—may necessitate decontamination. All patients with environmental exposure should undergo decontamination.[2][3][22]

As CS2 toxicity often presents with many nonspecific symptoms, clinicians should consider and rule out multiple alternative diagnoses when evaluating a patient with suspected CS2 exposure. Common conditions with similar presentations include: Viral infection Pneumonia Gastroenteritis Tension headache Migraines Vertigo Asthma Chronic obstructive pulmonary disease exacerbation Meningitis Medication overdose Pulmonary embolism, Other toxic exposures, such as carbon monoxide and toxic alcohols Metal fume fever Pneumoconioses

The prognosis of CS2 toxicity depends on the intensity and duration of exposure, as well as the timeliness of medical intervention. Although the severity of the toxic effects of CS2 can vary considerably among individuals, it generally leads to progressive symptoms with increasing exposure levels. However, evidence suggests that significant exposures are associated with significant impacts on health and an increased risk of mortality. However, the effects of moderate exposure remain less well understood, and the timeline for recovery and return to baseline functioning is unclear.[1][4] Low-level exposure to CS2, typically at concentrations below 20 ppm, may cause symptoms such as headache, dizziness, fatigue, nausea, and irritation of the eyes and skin. Individuals with low exposure generally recover well without severe long-term effects. Moderate or intermediate exposures, ranging from 20 to 100 ppm, can result in more pronounced symptoms, including muscle weakness, mood changes, memory impairment, peripheral neuropathy, and shortness of breath. Recovery in these cases is variable and largely depends on both the duration and intensity of exposure. With intermediate exposure to CS2, recovery outcomes can vary. Some individuals may achieve full recovery, while others may experience only partial improvement. Persistent symptoms, including fatigue, neurological complaints, or respiratory issues, can persist for weeks to months, and some individuals may not fully recover to their baseline. Prolonged exposure at intermediate concentrations may also increase the long-term risk of cardiovascular disease and neurological complications, including memory impairment and peripheral neuropathy. High levels of CS2 exposure, typically concentrations above 100 ppm, can lead to severe complications. Affected individuals may present with acute respiratory distress, significant neurological impairment, or coma. In addition to the immediate risks, high-level exposures are associated with long-term complications, including cardiovascular, reproductive, and thyroid dysfunction.[28] The prognosis for individuals exposed to high concentrations or prolonged exposure is generally poor. Without prompt removal from the source and appropriate treatment, outcomes may include respiratory failure, cardiovascular collapse, or death.[2]

Complications from acute CS2 toxicity primarily result from CNS depression and respiratory system compromise. As discussed, management is focused on supportive care. Chronic exposure to CS2 can affect multiple organ systems, and has been associated with renal disease, including chronic kidney disease; cardiovascular diseases such as coronary artery disease and hyperlipidemia; and CNS effects, including microvascular changes, which may lead to memory and cognition decline.[2][3][17][27][28]

Educating workers on how to minimize exposure in the workplace, along with recognizing early signs and symptoms of toxicity, is essential for the timely detection of acute CS2 exposure. Ongoing education and routine monitoring for individuals employed in industries that use CS2 can help identify and manage chronic health conditions resulting from prolonged exposure. As with any hazardous exposure, the use of appropriate personal protective equipment (PPE) is critical to ensuring safety.[1]

Effective care for individuals presenting with acute CS2 toxicity requires a coordinated interprofessional approach and foundational knowledge of expected symptoms and management strategies. All members of the healthcare team should be familiar with the clinical signs of acute toxicity, including those indicating severe illness, to ensure prompt recognition and timely intervention. Understanding that the risk of secondary contamination is minimal and that decontamination, when needed, can be performed quickly and safely is important. When managing the sequelae of chronic CS2 exposure, a strong interprofessional team dynamic is essential for both detection and ongoing care. This includes routine screening for chronic conditions, particularly those affecting the pulmonary, cardiovascular, and renal systems. All healthcare team members, including providers, nurses, social workers, and care coordinators, play a role in identifying and managing the long-term effects of exposure. Coordinating appointments across multiple specialties and ensuring that patients have access to and understand how to use prescribed medications and therapies are also key to improving long-term outcomes.